Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Genome-wide analysis reveals loci encoding anti-macrophage factors in the human pathogen Burkholderia pseudomallei K96243.

Dowling AJ, Wilkinson PA, Holden MT, Quail MA, Bentley SD, Reger J, Waterfield NR, Titball RW, Ffrench-Constant RH.

PLoS One. 2010 Dec 22;5(12):e15693. doi: 10.1371/journal.pone.0015693.

2.

Characterization of the Burkholderia pseudomallei K96243 capsular polysaccharide I coding region.

Cuccui J, Milne TS, Harmer N, George AJ, Harding SV, Dean RE, Scott AE, Sarkar-Tyson M, Wren BW, Titball RW, Prior JL.

Infect Immun. 2012 Mar;80(3):1209-21. doi: 10.1128/IAI.05805-11. Epub 2012 Jan 17.

3.

Interrogation of the Burkholderia pseudomallei genome to address differential virulence among isolates.

Challacombe JF, Stubben CJ, Klimko CP, Welkos SL, Kern SJ, Bozue JA, Worsham PL, Cote CK, Wolfe DN.

PLoS One. 2014 Dec 23;9(12):e115951. doi: 10.1371/journal.pone.0115951. eCollection 2014. Erratum in: PLoS One. 2015;10(3):e0122178.

4.

Melioidosis: molecular aspects of pathogenesis.

Stone JK, DeShazer D, Brett PJ, Burtnick MN.

Expert Rev Anti Infect Ther. 2014 Dec;12(12):1487-99. doi: 10.1586/14787210.2014.970634. Epub 2014 Oct 14. Review.

5.

DBSecSys 2.0: a database of Burkholderia mallei and Burkholderia pseudomallei secretion systems.

Memišević V, Kumar K, Zavaljevski N, DeShazer D, Wallqvist A, Reifman J.

BMC Bioinformatics. 2016 Sep 20;17:387. doi: 10.1186/s12859-016-1242-z.

6.

Genome-wide identification and mapping of variable sequences in the genomes of Burkholderia mallei and Burkholderia pseudomallei.

Fushan A, Monastyrskaya G, Abaev I, Kostina M, Filyukova O, Pecherskih E, Sverdlov E.

Res Microbiol. 2005 Mar;156(2):278-88. Epub 2004 Dec 1.

PMID:
15748995
7.

Within-host evolution of Burkholderia pseudomallei over a twelve-year chronic carriage infection.

Price EP, Sarovich DS, Mayo M, Tuanyok A, Drees KP, Kaestli M, Beckstrom-Sternberg SM, Babic-Sternberg JS, Kidd TJ, Bell SC, Keim P, Pearson T, Currie BJ.

MBio. 2013 Jul 16;4(4). pii: e00388-13. doi: 10.1128/mBio.00388-13.

8.

Characterization of Burkholderia pseudomallei Strains Using a Murine Intraperitoneal Infection Model and In Vitro Macrophage Assays.

Welkos SL, Klimko CP, Kern SJ, Bearss JJ, Bozue JA, Bernhards RC, Trevino SR, Waag DM, Amemiya K, Worsham PL, Cote CK.

PLoS One. 2015 Apr 24;10(4):e0124667. doi: 10.1371/journal.pone.0124667. eCollection 2015.

10.

Quorum sensing negatively regulates multinucleate cell formation during intracellular growth of Burkholderia pseudomallei in macrophage-like cells.

Horton RE, Grant GD, Matthews B, Batzloff M, Owen SJ, Kyan S, Flegg CP, Clark AM, Ulett GC, Morrison N, Peak IR, Beacham IR.

PLoS One. 2013 May 21;8(5):e63394. doi: 10.1371/journal.pone.0063394. Print 2013.

11.

The cluster 1 type VI secretion system is a major virulence determinant in Burkholderia pseudomallei.

Burtnick MN, Brett PJ, Harding SV, Ngugi SA, Ribot WJ, Chantratita N, Scorpio A, Milne TS, Dean RE, Fritz DL, Peacock SJ, Prior JL, Atkins TP, Deshazer D.

Infect Immun. 2011 Apr;79(4):1512-25. doi: 10.1128/IAI.01218-10. Epub 2011 Feb 7.

12.

Activation of Toll-like receptors by Burkholderia pseudomallei.

West TE, Ernst RK, Jansson-Hutson MJ, Skerrett SJ.

BMC Immunol. 2008 Aug 8;9:46. doi: 10.1186/1471-2172-9-46.

13.

BPSS1504, a cluster 1 type VI secretion gene, is involved in intracellular survival and virulence of Burkholderia pseudomallei.

Hopf V, Göhler A, Eske-Pogodda K, Bast A, Steinmetz I, Breitbach K.

Infect Immun. 2014 May;82(5):2006-15. doi: 10.1128/IAI.01544-14. Epub 2014 Mar 4.

14.

Burkholderia thailandensis as a model system for the study of the virulence-associated type III secretion system of Burkholderia pseudomallei.

Haraga A, West TE, Brittnacher MJ, Skerrett SJ, Miller SI.

Infect Immun. 2008 Nov;76(11):5402-11. doi: 10.1128/IAI.00626-08. Epub 2008 Sep 8.

15.

Tandem repeat regions within the Burkholderia pseudomallei genome and their application for high resolution genotyping.

U'Ren JM, Schupp JM, Pearson T, Hornstra H, Friedman CL, Smith KL, Daugherty RR, Rhoton SD, Leadem B, Georgia S, Cardon M, Huynh LY, DeShazer D, Harvey SP, Robison R, Gal D, Mayo MJ, Wagner D, Currie BJ, Keim P.

BMC Microbiol. 2007 Mar 30;7:23.

16.

Burkholderia pseudomallei transcriptional adaptation in macrophages.

Chieng S, Carreto L, Nathan S.

BMC Genomics. 2012 Jul 23;13:328. doi: 10.1186/1471-2164-13-328.

17.

Novel gain of function approaches for vaccine candidate identification in Burkholderia pseudomallei.

Dowling AJ.

Front Cell Infect Microbiol. 2013 Jan 9;2:139. doi: 10.3389/fcimb.2012.00139. eCollection 2012. Review.

18.
19.

The molecular and cellular basis of pathogenesis in melioidosis: how does Burkholderia pseudomallei cause disease?

Lazar Adler NR, Govan B, Cullinane M, Harper M, Adler B, Boyce JD.

FEMS Microbiol Rev. 2009 Nov;33(6):1079-99. doi: 10.1111/j.1574-6976.2009.00189.x. Epub 2009 Aug 5. Review.

20.

The chemical arsenal of Burkholderia pseudomallei is essential for pathogenicity.

Biggins JB, Kang HS, Ternei MA, DeShazer D, Brady SF.

J Am Chem Soc. 2014 Jul 2;136(26):9484-90. doi: 10.1021/ja504617n. Epub 2014 Jun 24.

Supplemental Content

Support Center